Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2026-03-08 @ 1:47 AM
Study NCT ID:
NCT01711866
Status:
COMPLETED
Last Update Posted:
2014-04-07
First Post:
2012-10-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease
Sponsor:
UCB BIOSCIENCES GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09
Start Date Type:
None
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-18
First Submit QC Date:
None
Study First Post Date:
2012-10-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-02-25
Results First Submit QC Date:
None
Results First Post Date:
2014-04-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-25
Last Update Post Date:
2014-04-07
Last Update Post Date Type:
ESTIMATED